To include your compound in the COVID-19 Resource Center, submit it here.

Pegasys peginterferon alfa-2a and Copegus ribavirin regulatory update

The FDA's Anti-Viral Drugs Advisory Committee unanimously

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE